rs879254337
Variant summary
Our verdict is Uncertain significance. Variant got 2 ACMG points: 2P and 0B. PM2
The NM_000245.4(MET):c.3633-2A>G variant causes a splice acceptor, intron change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. 3/3 splice prediction tools predicting alterations to normal splicing. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_000245.4 splice_acceptor, intron
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
MET | NM_000245.4 | c.3633-2A>G | splice_acceptor_variant, intron_variant | Intron 18 of 20 | ENST00000397752.8 | NP_000236.2 | ||
MET | NM_001127500.3 | c.3687-2A>G | splice_acceptor_variant, intron_variant | Intron 18 of 20 | NP_001120972.1 | |||
MET | NM_001324402.2 | c.2343-2A>G | splice_acceptor_variant, intron_variant | Intron 17 of 19 | NP_001311331.1 | |||
MET | XM_011516223.2 | c.3690-2A>G | splice_acceptor_variant, intron_variant | Intron 19 of 21 | XP_011514525.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
MET | ENST00000397752.8 | c.3633-2A>G | splice_acceptor_variant, intron_variant | Intron 18 of 20 | 1 | NM_000245.4 | ENSP00000380860.3 | |||
MET | ENST00000318493.11 | c.3687-2A>G | splice_acceptor_variant, intron_variant | Intron 18 of 20 | 1 | ENSP00000317272.6 | ||||
MET | ENST00000436117.3 | n.*1238-2A>G | splice_acceptor_variant, intron_variant | Intron 17 of 19 | 1 | ENSP00000410980.2 |
Frequencies
GnomAD3 genomes Cov.: 33
GnomAD4 exome Cov.: 31
GnomAD4 genome Cov.: 33
ClinVar
Submissions by phenotype
Renal cell carcinoma Uncertain:1
This sequence change affects an acceptor splice site in intron 18 of the MET gene. It is expected to disrupt mRNA splicing and likely results in an absent or disrupted protein product. While this particular variant has not been reported in the literature, truncating variants in MET are not necessarily pathogenic (PMID: 9140397), and the clinical significance of this variant is uncertain at this time. In summary, this is a novel variant and without additional functional and/or genetic data, it has been classified as a Variant of Uncertain Significance. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at